{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T02:27:52Z","timestamp":1788834472291,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The therapeutic effect and molecular mechanism of the Liusizi Decoction on cachexia and muscle atrophy in gastric cancer through AMPK\u00ce\u00b12-mediated glucose metabolism reprogramming","award":["S2025-JC-YB-1694"],"award-info":[{"award-number":["S2025-JC-YB-1694"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,5]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Renal cell carcinoma (RCC) represents one of the most common malignant tumors of the urinary system, characterized by high heterogeneity and aggressiveness. Studies indicate that matrix metalloproteinase-9 (MMP9) plays a critical role in the invasion, metastasis, and prognosis of RCC, and is recognized as a potential molecular biomarker and therapeutic target. This study aims to develop a radiomics-based prediction model for noninvasive identification of MMP9 expression levels in RCC patients and to assess its clinical relevance in patient prognosis. This retrospective study utilized enhanced computed tomography images and clinical data from The Cancer Genome Atlas database. We manually delineated volumes of interest, extracted radiomic features, and performed standardization procedures. Key features were selected using minimum redundancy maximum relevance and recursive feature elimination algorithms, followed by the construction of a radiomics model for predicting MMP9 expression through the gradient boosting machine algorithm. Survival analysis was performed using Kaplan\u2013Meier curves and Cox proportional hazards regression models. Furthermore, immune cell infiltration analysis and enrichment analysis were employed to explore the underlying biological mechanisms associated with MMP9. MMP9 demonstrated independent prognostic value in RCC patients (hazard ratio\u2005=\u20051.447). The radiomics model incorporating 3 features, constructed using multiple machine learning algorithms, exhibited favorable predictive performance for MMP9 expression levels (area under the curve\u2005=\u20050.865). The radiomics score mapping MMP9 expression levels served as an independent risk predictor for RCC patients (hazard ratio\u2005=\u20052.287, 95% confidence interval\u2005=\u20051.025\u20135.103,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.043). Furthermore, MMP9 correlates with pathways such as immune response regulation signals, carbon metabolism, and PI3K-Akt, as well as immune cell infiltration, including M2-type macrophages and regulatory T cells. MMP9 serves as an independent prognostic factor in RCC. The enhanced computed tomography radiomics model composed of 3 features can noninvasively predict MMP9 expression levels in RCC patients.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048992","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:42Z","timestamp":1780718502000},"page":"e48992","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["A CT-based radiomics model for noninvasive prediction of MMP9 expression and prognostic evaluation in renal cell carcinoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Sijia","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Postgraduate Work, Xi\u2019an Medical University, Xi\u2019an, Shaanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8820-2173","authenticated-orcid":false,"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Traditional Chinese Medicine, Tangdu Hospital, Fourth Military Medical University, Xi\u2019an, Shaanxi Province, China"},{"name":"Key Laboratory of Integrated Traditional Chinese and Western Medicine Tumor Diagnosis and Treatment in Shaanxi Province, Xi\u2019an, Shaanxi Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260711","first-page":"7","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"R2-20260711","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal cell carcinoma.","volume":"332","author":"Rose","year":"2024","journal-title":"JAMA"},{"key":"R3-20260711","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","article-title":"Renal cell carcinoma.","volume":"404","author":"Young","year":"2024","journal-title":"Lancet (Lond)"},{"key":"R4-20260711","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.euo.2025.05.007","article-title":"Global trends in the incidence, mortality, and risk-attributable deaths for prostate, bladder, and kidney cancers: a systematic analysis from the global burden of disease study 2021.","volume":"8","author":"Leung","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"R5-20260711","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H","article-title":"Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.","volume":"80","author":"Bukowski","year":"1997","journal-title":"Cancer"},{"key":"R6-20260711","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","article-title":"Epidemiology of renal cell carcinoma.","volume":"11","author":"Padala","year":"2020","journal-title":"World J Oncol"},{"key":"R7-20260711","article-title":"Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.","volume":"39","author":"Bahadoram","year":"2022","journal-title":"G Ital Nefrol"},{"key":"R8-20260711","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11864-023-01161-5","article-title":"Treatment landscape of renal cell carcinoma.","volume":"24","author":"Chen","year":"2023","journal-title":"Curr Treat Options Oncol"},{"key":"R9-20260711","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41598-024-83154-4","article-title":"Long non-coding RNA OSTM1-AS1 promotes renal cell carcinoma progression by sponging miR-491-5p and upregulating MMP-9.","volume":"15","author":"Chen","year":"2025","journal-title":"Sci Rep"},{"key":"R10-20260711","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7150\/ijms.58902","article-title":"G6PD upregulates cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression.","volume":"19","author":"Zhang","year":"2022","journal-title":"Int J Med Sci"},{"key":"R11-20260711","doi-asserted-by":"crossref","first-page":"737","DOI":"10.32604\/or.2023.042925","article-title":"Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC).","volume":"32","author":"Li","year":"2024","journal-title":"Oncol Res"},{"key":"R12-20260711","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12967-023-04437-4","article-title":"Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis.","volume":"21","author":"Kang","year":"2023","journal-title":"J Transl Med"},{"key":"R13-20260711","doi-asserted-by":"crossref","first-page":"216380","DOI":"10.1016\/j.canlet.2023.216380","article-title":"Noninvasive radiomics model reveals macrophage infiltration in glioma.","volume":"573","author":"Fan","year":"2023","journal-title":"Cancer Lett"},{"key":"R14-20260711","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nbt.3772","article-title":"Toil enables reproducible, open source, big biomedical data analyses.","volume":"35","author":"Vivian","year":"2017","journal-title":"Nat Biotechnol"},{"key":"R15-20260711","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data.","volume":"19","author":"Xu","year":"2024","journal-title":"Nat Protoc"},{"key":"R16-20260711","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"R17-20260711","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00259-025-07453-2","article-title":"Predicting PD-L1 expression status in NSCLC using radiomic analysis of 18F-FDG-PET\/CT images.","volume":"53","author":"Kiss","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-20260711","doi-asserted-by":"crossref","first-page":"469.e19","DOI":"10.1016\/j.urolonc.2025.02.016","article-title":"Transcriptomic and proteo-metabolic determinants of the grading system in clear cell renal cell carcinoma.","volume":"43","author":"Lucarelli","year":"2025","journal-title":"Urol Oncol"},{"key":"R19-20260711","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/14737159.2023.2195553","article-title":"The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery.","volume":"23","author":"di Meo","year":"2023","journal-title":"Expert Rev Mol Diagn"},{"key":"R20-20260711","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/14737159.2019.1607729","article-title":"Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma.","volume":"19","author":"Lucarelli","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"R21-20260711","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.3390\/ijms232214360","article-title":"Renal cell carcinoma as a metabolic disease: an update on main pathways, potential biomarkers, and therapeutic targets.","volume":"23","author":"Di Meo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R22-20260711","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1158\/2159-8290.CD-19-0499","article-title":"Tumor microenvironment dynamics in clear-cell renal cell carcinoma.","volume":"9","author":"Vuong","year":"2019","journal-title":"Cancer Discov"},{"key":"R23-20260711","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-016-0841-9","article-title":"miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction.","volume":"14","author":"Gigante","year":"2016","journal-title":"J Transl Med"},{"key":"R24-20260711","doi-asserted-by":"crossref","first-page":"16515","DOI":"10.3390\/ijms242216515","article-title":"Complement system and the kidney: its role in renal diseases, kidney transplantation and renal cell carcinoma.","volume":"24","author":"Lasorsa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R25-20260711","doi-asserted-by":"crossref","first-page":"2592962","DOI":"10.1155\/2022\/2592962","article-title":"Prognostic and immunological roles of MMP-9 in pan-cancer.","volume":"2022","author":"Zeng","year":"2022","journal-title":"Biomed Res Int"},{"key":"R26-20260711","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.3390\/cancers15225475","article-title":"Higher content but no specific activity in gelatinase B (MMP-9) compared with gelatinase A (MMP-2) in human renal carcinoma.","volume":"15","author":"Mlynarczyk","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R27-20260711","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12885-021-07860-2","article-title":"Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.","volume":"21","author":"Jiang","year":"2021","journal-title":"BMC Cancer"},{"key":"R28-20260711","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/CBM-170901","article-title":"Effects of various treatment approaches for treatment efficacy for late stage breast cancer and expression level of TIMP-1 and MMP-9.","volume":"23","author":"Yuan","year":"2018","journal-title":"Cancer Biomark"},{"key":"R29-20260711","first-page":"1358","article-title":"Expression and clinical significance of MMP-9 and P53 in lung cancer.","volume":"25","author":"Zhang","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R30-20260711","doi-asserted-by":"crossref","first-page":"878639","DOI":"10.3389\/fonc.2022.878639","article-title":"PRL-3 and MMP9 expression and epithelial-mesenchymal transition markers in circulating tumor cells from patients with colorectal cancer: potential value in clinical practice.","volume":"12","author":"Hong","year":"2022","journal-title":"Front Oncol"},{"key":"R31-20260711","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12575-023-00196-0","article-title":"Macrophage-derived MMP-9 and MMP-2 are closely related to the rupture of the fibrous capsule of hepatocellular carcinoma leading to tumor invasion.","volume":"25","author":"Cui","year":"2023","journal-title":"Biol Proced Online"},{"key":"R32-20260711","doi-asserted-by":"crossref","first-page":"10732748211033743","DOI":"10.1177\/10732748211033743","article-title":"Prognostic role of matrix metalloproteinases in cervical cancer: a meta-analysis.","volume":"28","author":"Chen","year":"2021","journal-title":"Cancer Control"},{"key":"R33-20260711","doi-asserted-by":"crossref","first-page":"155024","DOI":"10.1016\/j.prp.2023.155024","article-title":"Metalloproteinase 9 immunostaining profile is positively correlated with tumor grade, extraprostatic extension and biochemical recurrence in prostate cancer.","volume":"253","author":"Pinheiro","year":"2024","journal-title":"Pathol Res Pract"},{"key":"R34-20260711","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/path.5568","article-title":"SETDB1 promotes gastric carcinogenesis and metastasis via upregulation of CCND1 and MMP9 expression.","volume":"253","author":"Shang","year":"2021","journal-title":"J Pathol"},{"key":"R35-20260711","doi-asserted-by":"crossref","first-page":"1325447","DOI":"10.3389\/fphar.2024.1325447","article-title":"Identification of molecular subtypes and diagnostic model in clear cell renal cell carcinoma based on collagen-related genes may predict the response of immunotherapy.","volume":"15","author":"Hong","year":"2024","journal-title":"Front Pharmacol"},{"key":"R36-20260711","doi-asserted-by":"crossref","first-page":"108082","DOI":"10.1016\/j.compbiolchem.2024.108082","article-title":"Exploring the role of coagulation-related genes in renal cell carcinoma: implications for tumor microenvironment and prognostic biomarkers.","volume":"110","author":"Qiu","year":"2024","journal-title":"Comput Biol Chem"},{"key":"R37-20260711","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.3390\/cancers14071847","article-title":"MMP9: a tough target for targeted therapy for cancer.","volume":"14","author":"Augoff","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R38-20260711","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10555-025-10278-y","article-title":"Metastasis-promoting functions of myeloid cells.","volume":"44","author":"Kusmartsev","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"R39-20260711","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13046-023-02742-w","article-title":"TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma.","volume":"42","author":"Xu","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"R40-20260711","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","article-title":"Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.","volume":"39","author":"Braun","year":"2021","journal-title":"Cancer Cell"},{"key":"R41-20260711","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41419-020-2518-9","article-title":"MUC15 inhibits cancer metastasis via PI3K\/AKT signaling in renal cell carcinoma.","volume":"11","author":"Yue","year":"2020","journal-title":"Cell Death Dis"},{"key":"R42-20260711","doi-asserted-by":"crossref","first-page":"115590","DOI":"10.1016\/j.bcp.2023.115590","article-title":"Free-fatty acid receptor-4 (FFA4\/GPR120) differentially regulates migration, invasion, proliferation and tumor growth of papillary renal cell carcinoma cells.","volume":"213","author":"Karmokar","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"R43-20260711","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype.","volume":"77","author":"Van Griethuysen","year":"2017","journal-title":"Cancer Res"},{"key":"R44-20260711","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1007\/s00259-022-05773-1","article-title":"The radiomics-based tumor heterogeneity adds incremental value to the existing prognostic models for predicting outcome in localized clear cell renal cell carcinoma: a multicenter study.","volume":"49","author":"Yang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R45-20260711","doi-asserted-by":"crossref","first-page":"100440","DOI":"10.1016\/j.ejro.2022.100440","article-title":"Feasibility of using CT radiomic signatures for predicting CD8-T cell infiltration and PD-L1 expression in renal cell carcinoma.","volume":"9","author":"Varghese","year":"2022","journal-title":"Eur J Radiol Open"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:02:10Z","timestamp":1783778530000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":45,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048992","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"assertion":[{"value":"2025-12-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}